To determine a molecular mechanism that can account for this remarkable DNA protective effect of CTRP8, we assessed the amounts of key cellular BER proteins in the patient GBM‐1/2 models (Fig. 3B; Fig. S5A) and U87MG (Fig. 3C). The gene discussed is C1QTNF8; the disease is glioblastoma.